When a tumor starts to grow in the body, small bits of its genetic material may break away and float off into the bloodstream. This so-called cell free DNA can be used to identify cancer at very early ...

After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...

A mysterious RNA molecule found only in breast cancer led researchers on a six-year hunt that uncovered an entire hidden layer of cancer biology. The story began with T3p, a tiny RNA molecule found in ...

Researchers have identified cancer-specific RNAs and employed machine learning models to use them as a blood-based biomarker ...

University of Chicago researchers have developed a liquid biopsy test based on modification patterns in microbiome-derived cell-free RNA that predicts colorectal cancer (CRC) with greater accuracy ...

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...

Northwestern University in Illinois, US, has announced a new method for detecting RNA modification patterns in blood samples that could enhance early colon cancer detection. This was detailed in a ...

Children born before 37 weeks of gestation have a considerably increased risk of dying before they reach the age of five. Predicting the risk of preterm birth (PTB) and hence implementing preventive ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...